Please try another search
PARIS - Sanofi (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting April 1,...
PARIS - Sanofi (NASDAQ:SNY), the French multinational pharmaceutical company, reported a solid performance for the fourth quarter of 2023, with a 9.3% growth in sales at constant exchange rates...
WORLDWIDE – The global initial public offering (IPO) market is poised for a resurgence in 2024, as companies across various regions gear up for significant listings. In Asia, Alibaba (NYSE:BABA)'s...
PARIS - UBS has maintained its neutral stance on the pharmaceutical company Sanofi (NASDAQ:SNY), setting a target price of €100. This valuation reflects the company's confidence in its drug...
Investing.com - European stock markets traded in a mixed fashion Friday, as investors digested a week of corporate earnings, important central bank decisions and economic data. At 03:55 ET (07:55...
By Scott Kanowsky Investing.com -- Shares in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rose on Friday after the drugmaker posted better-than-expected earnings in the fourth quarter despite a dip in...
By Scott Kanowsky Investing.com -- European equities were broadly lower on Friday, as investors poured over disappointing results from major tech sector players and looked ahead to key U.S. labor...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review